The Adjuvant BcfA Activates Antigen Presenting Cells Through TLR4 and Supports T and T1 While Attenuating T2 Gene Programming

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Sep 13

PMID 39267766

Authors

Mohamed M Shamseldin

Kaitlin A Read

Jesse M Hall

Jasmine A Tuazon

Jessica M Brown

Myra Guo

Yash A Gupta

Rajendar Deora

Kenneth J Oestreich

Purnima Dubey

Affiliations

Soon will be listed here.

Abstract

Introduction: Adjuvants added to subunit vaccines augment antigen-specific immune responses. One mechanism of adjuvant action is activation of pattern recognition receptors (PRRs) on innate immune cells. colonization factor A (BcfA); an outer membrane protein with adjuvant function, activates T1/T17-polarized immune responses to protein antigens from and SARS CoV-2. Unlike other adjuvants, BcfA does not elicit a T2 response.

Methods: To understand the mechanism of BcfA-driven T1/T17 vs. T2 activation, we screened PRRs to identify pathways activated by BcfA. We then tested the role of this receptor in the BcfA-mediated activation of bone marrow-derived dendritic cells (BMDCs) using mice with germline deletion of TLR4 to quantify upregulation of costimulatory molecule expression and cytokine production in vitro and in vivo. Activity was also tested on human PBMCs.

Results: PRR screening showed that BcfA activates antigen presenting cells through murine TLR4. BcfA-treated WT BMDCs upregulated expression of the costimulatory molecules CD40, CD80, and CD86 and produced IL-6, IL-12/23 p40, and TNF-α while TLR4 KO BMDCs were not activated. Furthermore, human PBMCs stimulated with BcfA produced IL-6. BcfA-stimulated murine BMDCs also exhibited increased uptake of the antigen DQ-OVA, supporting a role for BcfA in improving antigen presentation to T cells. BcfA further activated APCs in murine lungs. Using an T cell polarization system, we found that BcfA-stimulated BMDC supernatant supported T and T1 while suppressing T2 gene programming.

Conclusions: Overall, these data provide mechanistic understanding of how this novel adjuvant activates immune responses.

References

Jennings-Gee J, Quataert S, Ganguly T, DAgostino Jr R, Deora R, Dubey P . The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs. Infect Immun. 2018; 86(6). PMC: 5964531. DOI: 10.1128/IAI.00935-17. View

Ross P, Sutton C, Higgins S, Allen A, Walsh K, Misiak A . Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog. 2013; 9(4):e1003264. PMC: 3617212. DOI: 10.1371/journal.ppat.1003264. View

Canelle Q, Dewe W, Innis B, van der Most R . Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™. Hum Vaccin Immunother. 2016; 12(9):2289-98. PMC: 5027709. DOI: 10.1080/21645515.2016.1168954. View

Lyadova I, Panteleev A . Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers. Mediators Inflamm. 2015; 2015:854507. PMC: 4657112. DOI: 10.1155/2015/854507. View

Choi H, Kim W, Back Y, Kim H, Kwon K, Kim J . Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells. Eur J Immunol. 2015; 45(7):1957-71. DOI: 10.1002/eji.201445329. View

Wang W, Li J, Wu K, Azhati B, Rexiati M . Culture and Identification of Mouse Bone Marrow-Derived Dendritic Cells and Their Capability to Induce T Lymphocyte Proliferation. Med Sci Monit. 2016; 22:244-50. PMC: 4729227. DOI: 10.12659/msm.896951. View

Coffman R, Sher A, Seder R . Vaccine adjuvants: putting innate immunity to work. Immunity. 2010; 33(4):492-503. PMC: 3420356. DOI: 10.1016/j.immuni.2010.10.002. View

Poon M, Rybkina K, Kato Y, Kubota M, Matsumoto R, Bloom N . SARS-CoV-2 infection generates tissue-localized immunological memory in humans. Sci Immunol. 2021; 6(65):eabl9105. PMC: 8626868. DOI: 10.1126/sciimmunol.abl9105. View

Gane J, Stockley R, Sapey E . TNF- Autocrine Feedback Loops in Human Monocytes: The Pro- and Anti-Inflammatory Roles of the TNF- Receptors Support the Concept of Selective TNFR1 Blockade . J Immunol Res. 2016; 2016:1079851. PMC: 5055993. DOI: 10.1155/2016/1079851. View

10.

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

11.

Han J, Wui S, Kim K, Cho Y, Cho W, Lee N . Characterization of the structure and immunostimulatory activity of a vaccine adjuvant, de-O-acylated lipooligosaccharide. PLoS One. 2014; 9(1):e85838. PMC: 3899070. DOI: 10.1371/journal.pone.0085838. View

12.

Kabelitz D . Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol. 2006; 19(1):39-45. DOI: 10.1016/j.coi.2006.11.007. View

13.

Pulendran B, Arunachalam P, OHagan D . Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov. 2021; 20(6):454-475. PMC: 8023785. DOI: 10.1038/s41573-021-00163-y. View

14.

Del Giudice G, Rappuoli R, Didierlaurent A . Correlates of adjuvanticity: A review on adjuvants in licensed vaccines. Semin Immunol. 2018; 39:14-21. DOI: 10.1016/j.smim.2018.05.001. View

15.

Chatzikleanthous D, OHagan D, Adamo R . Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines. Mol Pharm. 2021; 18(8):2867-2888. DOI: 10.1021/acs.molpharmaceut.1c00447. View

16.

Wilk M, Mills K . CD4 T Cells Following Infection and Immunization: Implications for More Effective Vaccine Design. Front Immunol. 2018; 9:1860. PMC: 6095996. DOI: 10.3389/fimmu.2018.01860. View

17.

Crotty S . T follicular helper cell differentiation, function, and roles in disease. Immunity. 2014; 41(4):529-42. PMC: 4223692. DOI: 10.1016/j.immuni.2014.10.004. View

18.

Ebensen T, Delandre S, Prochnow B, Guzman C, Schulze K . The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization. Front Cell Infect Microbiol. 2019; 9:31. PMC: 6390046. DOI: 10.3389/fcimb.2019.00031. View

19.

Krieg A . An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA. J Lab Clin Med. 1996; 128(2):128-33. DOI: 10.1016/s0022-2143(96)90004-9. View

20.

Facciola A, Visalli G, Lagana A, Di Pietro A . An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Vaccines (Basel). 2022; 10(5). PMC: 9147349. DOI: 10.3390/vaccines10050819. View